Skip to content

Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations

Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03802825
Enrollment
110
Registered
2019-01-14
Start date
2019-03-01
Completion date
2021-06-30
Last updated
2022-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

In this pilot and feasibility study, the investigator will randomize 100 African-American, Hispanic, and/or Medicaid (all race/ethnicities) patients from KPNW with A1C ≥ 8 to one of two 6-month interventions: 1) patient navigation only; or 2) patient navigation + diabetes self-management training. Feasibility of a large-scale, pragmatic, randomized trial will be determined and preliminary effectiveness of treatment arms on A1C reduction among racial/ethnic minority and low-income patients with poorly managed diabetes will be examined.

Detailed description

The purpose of this feasibility study is to inform the design of a future large-scale, randomized trial that will test if there is added benefit to addressing both social and economic needs and diabetes self-management to improve diabetes management long-term among vulnerable populations. In this pilot, the investigator will randomize 100 African-American, Hispanic, and/or Medicaid (all race/ethnicities) patients from Kaiser Permanente Northwest (KPNW) with A1C ≥ 8 and poor follow-up in primary care to one of two 6-month interventions: 1) patient navigation only; or 2) patient navigation + diabetes self-management training. In both study arms, KPNW practice-embedded patient navigators will screen for medical, social and economic needs and connect participants to internal and external resources. In the second study arm, navigators will also refer participants to community health workers (CHWs) embedded in local community-based organizations, who will deliver diabetes self-management training. Feasibility of the full-scale trial will be based on several measures including recruitment, retention, success rate of referrals to navigators and CHWs, and whether medical, social, and/or economic needs are met. Qualitative interviews will be conducted with various stakeholders to assess intervention acceptability and determinants of implementation. Preliminary effects of A1C, diabetes-related care gaps, health care utilization, and medication adherence will also be examined. This pragmatic study design involves a collaborative effort among researchers, health system staff, health system senior leadership, and local community-based organizations. Findings from the full-scale trial will contribute critical knowledge on the most effective, sustainable model of care for integrating lay health workers in the efforts to improve diabetes management among high risk patient populations.

Interventions

BEHAVIORALDiabetes Self-Management Training

The Decision-making Education for Choices in Diabetes Everyday (DECIDE) program is a nine-module, literacy adapted diabetes and cardiovascular disease education and problem-solving training program. Participants are taught the five steps of problem solving with each module going in depth on a single step: 1) identify the problem; 2) brainstorm possible strategies for problem resolution; 3) select the most appropriate strategy; 4) apply the strategy; 5) evaluate the effectiveness of the strategy. During the six months, CHWs will have weekly or bi-weekly contact with participants in-person or by phone to deliver the DECIDE modules and address social and economic needs.

OTHERStandard Patient Navigation

Once the participant has completed the YCLS assessment with study staff, the navigator will receive the referral and follow-up with the participant to address the social and economic needs identified. The patient navigator will follow-up with the participant 2-3 times over the 6 months by phone or in-person about progress with the referral and help address additional needs that may develop during the 6-month intervention.

Sponsors

Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Eligibility criteria for all study participants is a diagnosis of diabetes with A1C ≥ 8.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diabetes diagnosis * Current Kaiser Permanente Northwest member * African-American, Hispanic/Latino (English, Spanish-speaking, or bilingual), and/or a Medicaid recipient (from any racial or ethnic background) * Age 18 or older * Most recent hemoglobin A1C test of ≥ 8 * Endorses 1 or more social and/or economic need on the Your Current Life Situation assessment

Exclusion criteria

* Patients who are unable to provide informed consent due to cognitive or psychiatric impairment.

Design outcomes

Primary

MeasureTime frameDescription
Percent of Participants With A1C < 8%6 monthsUsing ITT analysis, percent of participants in each arm with A1C \< 8% at 6-month follow-up was calculated.

Secondary

MeasureTime frameDescription
Emergency Department (ED) Visits6 monthsMean number of visits to the emergency department over the 6-month duration of the intervention.
Primary Care Visit No-show Rate6 monthsMean number of missed primary care visits over duration of the intervention (6 months)
Medication Refills6 monthsNumber of participants with 1 or more gaps in refilling oral diabetes medications during the study period. A gap is defined as not refilling prescription for 7 or more days after prescription has ran out.
Mean A1C Change6 monthsChange in A1C from baseline to 6-month follow-up

Countries

United States

Participant flow

Recruitment details

We used a targeted recruitment approach by first identifying potentially eligible patients in the electronic health record (EHR) and then emailing or mailing recruitment letters. Letters were followed by a phone call from study staff who described the study and further assessed eligibility by confirming race/ethnicity and health coverage and administering a social risks screener.

Participants by arm

ArmCount
Patient Navigation
Participants randomized to the patient navigation only arm will be referred to a KPNW patient navigator using a standard electronic health record-based referral process. Once the participant has completed the Your Current Life Situation (YCLS) assessment with study staff, the navigator will receive the referral and follow-up with the participant to address the social and economic needs identified. The patient navigator will follow-up with the participant 2-3 times over the 6 month period by phone or in-person about progress with the referral and help address additional needs that may develop during the 6-month intervention. Participant will also receive monthly mailing of American Diabetes Association educational materials. Standard Patient Navigation: Once the participant has completed the YCLS assessment with study staff, the navigator will receive the referral and follow-up with the participant to address the social and economic needs identified. The patient navigator will follow-up with the participant 2-3 times over the 6 months by phone or in-person about progress with the referral and help address additional needs that may develop during the 6-month intervention.
54
Patient Navigation+Diabetes Self-Management Support
In addition to receiving navigation, participants in this arm will also be referred to Project Access NOW by study staff using REDCap. Project Access NOW will connect participants to a community-based organization based on their preference, previous experience with an agency, geography, and capacity. The CHW will follow-up with the participant to conduct a home visit and follow-up on community-based referrals already placed by the KPNW patient navigator and assess for additional needs. The timing of the diabetes self-management training will be based on the needs of the participant. Diabetes Self-Management Training: The Decision-making Education for Choices in Diabetes Everyday (DECIDE) program is a nine-module, literacy adapted diabetes and cardiovascular disease education and problem-solving training program. Participants are taught the five steps of problem solving with each module going in depth on a single step: 1) identify the problem; 2) brainstorm possible strategies for problem resolution; 3) select the most appropriate strategy; 4) apply the strategy; 5) evaluate the effectiveness of the strategy. During the six months, CHWs will have weekly or bi-weekly contract with participants in-person or by phone to deliver the DECIDE modules and address social and economic needs.
56
Total110

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to follow-up for intervention123
Overall StudyReceived only 1 component of intervention013

Baseline characteristics

CharacteristicTotalPatient Navigation+Diabetes Self-Management SupportPatient Navigation
A1C9.9 % of glycosylated hemoglobin
STANDARD_DEVIATION 1.7
9.8 % of glycosylated hemoglobin
STANDARD_DEVIATION 1.6
9.9 % of glycosylated hemoglobin
STANDARD_DEVIATION 1.7
Age, Continuous53.3 years
STANDARD_DEVIATION 12
53.7 years
STANDARD_DEVIATION 12.1
52.9 years
STANDARD_DEVIATION 12.1
Primary Language
English
96 Participants50 Participants46 Participants
Primary Language
Spanish
14 Participants6 Participants8 Participants
Race/Ethnicity, Customized
Black/African American
40 Participants21 Participants19 Participants
Race/Ethnicity, Customized
Hispanic/Latino
29 Participants13 Participants16 Participants
Race/Ethnicity, Customized
Multiple Races
3 Participants2 Participants1 Participants
Race/Ethnicity, Customized
White
38 Participants20 Participants18 Participants
Region of Enrollment
United States
110 participants56 participants54 participants
Sex: Female, Male
Female
77 Participants39 Participants38 Participants
Sex: Female, Male
Male
33 Participants17 Participants16 Participants
Types of Social Needs Reported
Financial Hardship
96 Participants45 Participants51 Participants
Types of Social Needs Reported
Food Insecurity
67 Participants33 Participants34 Participants
Types of Social Needs Reported
Insufficient Housing
33 Participants18 Participants15 Participants
Types of Social Needs Reported
Lack of Transportation
37 Participants19 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 541 / 56
other
Total, other adverse events
0 / 540 / 56
serious
Total, serious adverse events
7 / 547 / 56

Outcome results

Primary

Percent of Participants With A1C < 8%

Using ITT analysis, percent of participants in each arm with A1C \< 8% at 6-month follow-up was calculated.

Time frame: 6 months

Population: ITT was used for primary outcome analysis so all participants included.

ArmMeasureValue (NUMBER)
Patient NavigationPercent of Participants With A1C < 8%33 percent of participants
Patient Navigation+Diabetes Self-Management SupportPercent of Participants With A1C < 8%34 percent of participants
Secondary

Emergency Department (ED) Visits

Mean number of visits to the emergency department over the 6-month duration of the intervention.

Time frame: 6 months

Population: Analysis for this secondary outcome includes all participants.

ArmMeasureValue (MEAN)Dispersion
Patient NavigationEmergency Department (ED) Visits0.96 visitsStandard Deviation 1.7
Patient Navigation+Diabetes Self-Management SupportEmergency Department (ED) Visits1.07 visitsStandard Deviation 2.95
Secondary

Mean A1C Change

Change in A1C from baseline to 6-month follow-up

Time frame: 6 months

Population: ITT analysis was used for this outcome, so all participants were included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Patient NavigationMean A1C Change0.65 percentage of glycosylated hemoglobinStandard Deviation 1.76
Patient Navigation+Diabetes Self-Management SupportMean A1C Change0.72 percentage of glycosylated hemoglobinStandard Deviation 1.88
Secondary

Medication Refills

Number of participants with 1 or more gaps in refilling oral diabetes medications during the study period. A gap is defined as not refilling prescription for 7 or more days after prescription has ran out.

Time frame: 6 months

Population: Participants who were prescribed an oral diabetes medication during the study.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Patient NavigationMedication Refills27 Participants
Patient Navigation+Diabetes Self-Management SupportMedication Refills20 Participants
Secondary

Primary Care Visit No-show Rate

Mean number of missed primary care visits over duration of the intervention (6 months)

Time frame: 6 months

Population: All participants were included in the analysis for this secondary outcome.

ArmMeasureValue (MEAN)Dispersion
Patient NavigationPrimary Care Visit No-show Rate0.85 missed visitsStandard Deviation 1.29
Patient Navigation+Diabetes Self-Management SupportPrimary Care Visit No-show Rate0.88 missed visitsStandard Deviation 1.62

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026